These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 32112041)

  • 21. Glutamate and Parkinson's disease.
    Blandini F; Porter RH; Greenamyre JT
    Mol Neurobiol; 1996 Feb; 12(1):73-94. PubMed ID: 8732541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Akineto-rigid vs. tremor syndromes in Parkinsonism.
    Zaidel A; Arkadir D; Israel Z; Bergman H
    Curr Opin Neurol; 2009 Aug; 22(4):387-93. PubMed ID: 19494773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basal ganglia circuits changes in Parkinson's disease patients.
    Wu T; Wang J; Wang C; Hallett M; Zang Y; Wu X; Chan P
    Neurosci Lett; 2012 Aug; 524(1):55-9. PubMed ID: 22813979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease.
    Miguelez C; Morera-Herreras T; Torrecilla M; Ruiz-Ortega JA; Ugedo L
    Front Neural Circuits; 2014; 8():21. PubMed ID: 24672433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term depression at distinct glutamatergic synapses in the basal ganglia.
    Dupuis JP; Bioulac BH; Baufreton J
    Rev Neurosci; 2014; 25(6):741-54. PubMed ID: 25046307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distributed dopaminergic signaling in the basal ganglia and its relationship to motor disability in Parkinson's disease.
    Zhai S; Cui Q; Simmons DV; Surmeier DJ
    Curr Opin Neurobiol; 2023 Dec; 83():102798. PubMed ID: 37866012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preservation of function in Parkinson's disease: what's learning got to do with it?
    Beeler JA
    Brain Res; 2011 Nov; 1423():96-113. PubMed ID: 22000081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysfunctional and compensatory synaptic plasticity in Parkinson's disease.
    Schroll H; Vitay J; Hamker FH
    Eur J Neurosci; 2014 Feb; 39(4):688-702. PubMed ID: 24313650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Parkinson's disease and cortico-Basal Ganglia circuits].
    Pan MK; Tai CH; Kuo CC
    Acta Neurol Taiwan; 2010 Sep; 19(3):213-22. PubMed ID: 20824544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine and Acetylcholine, a Circuit Point of View in Parkinson's Disease.
    Rizzi G; Tan KR
    Front Neural Circuits; 2017; 11():110. PubMed ID: 29311846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant learning in Parkinson's disease: A neurocomputational study on bradykinesia.
    Ursino M; Baston C
    Eur J Neurosci; 2018 Jun; 47(12):1563-1582. PubMed ID: 29786160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bee Venom Alleviates Motor Deficits and Modulates the Transfer of Cortical Information through the Basal Ganglia in Rat Models of Parkinson's Disease.
    Maurice N; Deltheil T; Melon C; Degos B; Mourre C; Amalric M; Kerkerian-Le Goff L
    PLoS One; 2015; 10(11):e0142838. PubMed ID: 26571268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spike-Timing-Dependent Plasticity Mediated by Dopamine and its Role in Parkinson's Disease Pathophysiology.
    Madadi Asl M; Vahabie AH; Valizadeh A; Tass PA
    Front Netw Physiol; 2022; 2():817524. PubMed ID: 36926058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of inhibitory plasticity in basal ganglia output nuclei of patients with Parkinson's disease.
    Milosevic L; Gramer R; Kim TH; Algarni M; Fasano A; Kalia SK; Hodaie M; Lozano AM; Popovic MR; Hutchison WD
    Neurobiol Dis; 2019 Apr; 124():46-56. PubMed ID: 30391540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oscillatory activity in the cortico-basal ganglia-thalamic neural circuits in Parkinson's disease.
    Singh A
    Eur J Neurosci; 2018 Oct; 48(8):2869-2878. PubMed ID: 29381817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell Type-Specific Decrease of the Intrinsic Excitability of Motor Cortical Pyramidal Neurons in Parkinsonism.
    Chen L; Daniels S; Kim Y; Chu HY
    J Neurosci; 2021 Jun; 41(25):5553-5565. PubMed ID: 34006589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurokinin peptides and neurokinin receptors as potential therapeutic intervention targets of basal ganglia in the prevention and treatment of Parkinson's disease.
    Chen LW; Yung KK; Chan YS
    Curr Drug Targets; 2004 Feb; 5(2):197-206. PubMed ID: 15011953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional segregation of basal ganglia pathways in Parkinson's disease.
    Neumann WJ; Schroll H; de Almeida Marcelino AL; Horn A; Ewert S; Irmen F; Krause P; Schneider GH; Hamker F; Kühn AA
    Brain; 2018 Sep; 141(9):2655-2669. PubMed ID: 30084974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.